ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,872.81
0.12%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Allergy Therapeutics Plc (AGY)

  7. Allergy Therapeutics Plc (AGY) Noticias

AGY

Allergy Therapeutics (AGY)

Allergy Therapeutics Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:AGY
FechaHoraFuenteTítuloSímboloCompañía
07/05/202414:22Alliance NewsAlliance NewsTRADING UPDATES: Abingdon Health buys IVDeology HoldingsLSE:AGYAllergy Therapeutics Plc
07/05/202401:00RNS Regulatory NewsAllergy Therapeutics PLC Further detail from G306 Phase III field trialLSE:AGYAllergy Therapeutics Plc
03/04/202401:00RNS Regulatory NewsAllergy Therapeutics PLC Director ResignationLSE:AGYAllergy Therapeutics Plc
27/03/202411:13Alliance NewsAlliance NewsEARNINGS AND TRADING: Solid State ups outlook; Quartix trading in lineLSE:AGYAllergy Therapeutics Plc
27/03/202402:00RNS Regulatory NewsAllergy Therapeutics PLC Interim Results for six months ended 31 Dec 2023LSE:AGYAllergy Therapeutics Plc
27/03/202402:00RNS Regulatory NewsAllergy Therapeutics PLC Update on fundingLSE:AGYAllergy Therapeutics Plc
12/03/202409:06Alliance NewsAlliance NewsAllergy Therapeutics starts dosing patients in peanut allergy trialLSE:AGYAllergy Therapeutics Plc
12/03/202403:59RNS Regulatory NewsAllergy Therapeutics PLC VLP Peanut PROTECT Trial UpdateLSE:AGYAllergy Therapeutics Plc
11/03/202402:00RNS Regulatory NewsAllergy Therapeutics PLC Appointment of Shaun Furlong to Board of DirectorsLSE:AGYAllergy Therapeutics Plc
08/03/202407:49RNS Regulatory NewsAllergy Therapeutics PLC Result of AGMLSE:AGYAllergy Therapeutics Plc
14/02/202404:22Alliance NewsAlliance NewsAllergy Therapeutics forecasts revenue drop but trials going wellLSE:AGYAllergy Therapeutics Plc
14/02/202401:00RNS Regulatory NewsAllergy Therapeutics PLC Half-Year Trading Update 2024LSE:AGYAllergy Therapeutics Plc
09/02/202409:07RNS Regulatory NewsAllergy Therapeutics PLC Notice of 2023 Annual General MeetingLSE:AGYAllergy Therapeutics Plc
30/01/202404:38Alliance NewsAlliance NewsAllergy Therapeutics resumes trading on AIM; annual revenue plungesLSE:AGYAllergy Therapeutics Plc
30/01/202401:30RNS Regulatory NewsAIM Restoration - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
30/01/202401:00RNS Regulatory NewsAllergy Therapeutics PLC Publication of Annual Report and Accounts 2023LSE:AGYAllergy Therapeutics Plc
04/01/202406:29UK RegulatoryAllergy Therapeutics PLC Total Voting RightsLSE:AGYAllergy Therapeutics Plc
02/01/202401:30UK RegulatoryAIM Suspension - Allergy Therapeutics plcLSE:AGYAllergy Therapeutics Plc
27/12/202308:17Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics amends facility, plans warrant issueLSE:AGYAllergy Therapeutics Plc
27/12/202306:01UK RegulatoryAllergy Therapeutics PLC Amendment to existing Facility AgreementLSE:AGYAllergy Therapeutics Plc
15/12/202315:09Alliance NewsAlliance NewsEARNINGS AND TRADING: Redx full year revenue tumbles; loss widensLSE:AGYAllergy Therapeutics Plc
15/12/202306:48UK RegulatoryAllergy Therapeutics PLC Annual Report and Accounts DelayedLSE:AGYAllergy Therapeutics Plc
13/12/202310:54UK RegulatoryAllergy Therapeutics PLC PDMR dealing and Total Voting RightsLSE:AGYAllergy Therapeutics Plc
13/12/202304:11Alliance NewsAlliance NewsAllergy Therapeutics shares jump as hails grass allergy jab dataLSE:AGYAllergy Therapeutics Plc
13/12/202301:00UK RegulatoryAllergy Therapeutics PLC G306 Phase III trial meets key endpointsLSE:AGYAllergy Therapeutics Plc
11/12/202304:40Alliance NewsAlliance NewsIN BRIEF: Allergy Therapeutics stock falls on lower sales outlookLSE:AGYAllergy Therapeutics Plc
28/11/202309:03UK RegulatoryAllergy Therapeutics PLC Holding(s) in CompanyLSE:AGYAllergy Therapeutics Plc
14/11/202305:56Alliance NewsAlliance NewsAllergy Therapeutics says allergy therapy trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
14/11/202301:00UK RegulatoryAllergy Therapeutics PLC G306 Grass Phase III trial meets primary endpointLSE:AGYAllergy Therapeutics Plc
10/11/202308:39UK RegulatoryPanmure Gordon (UK) Limited Form 8.5 (EPT/RI)LSE:AGYAllergy Therapeutics Plc
 Showing the most relevant articles for your search:LSE:AGY

Su Consulta Reciente

USOTC
VPTDF
VentriPoint Diagnostics (QB)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados